Precision health will have important societal impact in understanding health and disease at a personalized level, and transforming how medicine is practiced. iPRIME seeks to customize healthcare, with medical decisions, treatments, practices, or products being tailored to the individual patient to optimize outcomes.

There are currently many challenges to implementing precision health, including insufficient technologies, limited knowledge, and gaps in implementation. We propose to help overcome these through an interdisciplinary approach, leveraging strengths at UVA. We focus this initial effort on cardiovascular disease (CVD) to achieve rapid and sustained preeminence in the area of immunomedicine for CVD. Yet, our platform can clearly be expanded going forward to include other fields of precision health.
Oom Pattarabanjird (MSTP trainee with the McNamara lab) received an award for top poster at the recent Atherosclerosis Gordon Conference
Oom Pattarabanjird (MSTP trainee with the McNamara lab) received an award for top poster at the recent Atherosclerosis Gordon Conference

Oom Pattarabanjird (MSTP trainee with the McNamara lab) received an award for top poster at the recent Atherosclerosis Gordon Conference in Barcelona for her poster entitled “Human Marginal Zone B cells Produce Atheroprotective IgM and Confer Protection from Vascular Disease.” … Read More

Dr. Loren Erickson and Dr. John Lukens received an NOA supplement for their project, IgE antibody responses to the oligosaccharide galactose-alpha-1,3-galactose (alpha-gal) in murine and human atherosclerosis 
Dr. Loren Erickson and Dr. John Lukens received an NOA supplement for their project, IgE antibody responses to the oligosaccharide galactose-alpha-1,3-galactose (alpha-gal) in murine and human atherosclerosis 

iPRIME members Dr. Loren Erickson and Dr. John Lukens received an NOA supplement for their project “IgE antibody responses to the oligosaccharide galactose-alpha-1,3-galactose (alpha-gal) in murine and human atherosclerosis”.  Congratulations to their team for their excellent work investigating the link between … Read More

Dr. Stefan Bekiranov and Dr. Aidong Zhang awarded an NSF grant titled, An Explainable Machine Learning Platform for Single Cell Data Analysis
Dr. Stefan Bekiranov and Dr. Aidong Zhang awarded an NSF grant titled, An Explainable Machine Learning Platform for Single Cell Data Analysis

Dr. Stefan Bekiranov, one of three PI’s of iPRIME &  Dr. Aidong Zhang, recipient of an iPRIME seed fund, have been awarded an NSF grant titled “An Explainable Machine Learning Platform for Single Cell Data Analysis” — this great work … Read More

Brett Ransegnola (McNamara lab) and Meritxell Nus (Mallat lab in Cambridge, UK) have been awarded a $50K Leducq Transatlantic Network of Excellence to study the role of Id3 in marginal zone B cells.
Brett Ransegnola (McNamara lab) and Meritxell Nus (Mallat lab in Cambridge, UK) have been awarded a $50K Leducq Transatlantic Network of Excellence to study the role of Id3 in marginal zone B cells.

Brett Ransegnola (McNamara lab) and Meritxell Nus (Mallat lab in Cambridge, UK) have been awarded a $50K Leducq Transatlantic Network of Excellence to study the role of Id3 in marginal zone B cells.   They recently met in NYC with the … Read More

There are no upcoming events at this time